Company intelligence / Profile preview

PROMED International

Ownership: Private
Development stage: Other

Overview

Promed Bioscience produces highly purified medical-grade atelocollagen from animal tissue using proprietary enzymatic extraction and dialysis purification. Their products are used globally in research, clinical, and cosmeceutical applications. The company emphasizes high biocompatibility, biodegradability, and low antigenicity of its collagen products.

Therapeutic areas: OtherDermatology
Modalities: BiomaterialProtein
Industry: Chemicals & Materials

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on PROMED International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PROMED International.